SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-002016
Filing Date
2017-08-09
Accepted
2017-08-09 17:15:52
Documents
39
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q proteo_10q-063017.htm 10-Q 176845
2 CERTIFICATION proteo_ex3101.htm EX-31.1 8986
3 CERTIFICATION proteo_ex3102.htm EX-31.2 9042
4 CERTIFICATION proteo_ex32.htm EX-32 5393
  Complete submission text file 0001683168-17-002016.txt   994569

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20170630.xml EX-101.INS 94911
6 XBRL SCHEMA FILE pteo-20170630.xsd EX-101.SCH 13623
7 XBRL CALCULATION FILE pteo-20170630_cal.xml EX-101.CAL 28714
8 XBRL DEFINITION FILE pteo-20170630_def.xml EX-101.DEF 22097
9 XBRL LABEL FILE pteo-20170630_lab.xml EX-101.LAB 91312
10 XBRL PRESENTATION FILE pteo-20170630_pre.xml EX-101.PRE 74486
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 171018876
SIC: 2834 Pharmaceutical Preparations